首页> 外文期刊>Ukrainian Biochemical Journal >Anti-inflammatory and hepatoprotective effects of polyherbal composition in patients with chronic cholecystitis
【24h】

Anti-inflammatory and hepatoprotective effects of polyherbal composition in patients with chronic cholecystitis

机译:聚乙烯组合物对慢性胆囊炎患者的抗炎和肝癌反应性

获取原文
           

摘要

Herbal preparations are widely used in the complementary treatment of inflammatory diseases including hepatobiliary disorders, among which chronic cholecystitis is one of the most common. This study was aimed to investigate the effect of the water extract from polyherbal composition consisting of eight medicinal plants ( Helichrysum arenarium, Mentha piperita, Calendula officinalis, Taraxacum officinale, Polygonum aviculare, Matricaria chamomilla, Portulaca oleracea, Hypericum perforatum ) on biochemical and haematologic indices as well as on immune reactivity parameters in patients with chronic cholecystitis. It was found that consumption of polyherbal tea during 45 days was followed by normalization of liver biochemical indices (serum level of cholesterol, alanine aminotransferase and aspartate aminotransferase activity, total and unconjugated bilirubin levels and diminution of hematological (leukocytosis, increased erythrocyte sedimentation rate and neutrophil-to-lymphocyte ratio) and immunological (increased serum level of pro-inflammatory cytokines) signs of systemic inflammation in patients with hepatobiliary disorder. The results of the research showed that the studied polygerbal composition can be recommended as a component of the complementary therapy for patients with chronic cholecystitis.
机译:草药制剂广泛应用于包括肝胆疾病,包括肝胆疾病的互补治疗,其中慢性胆囊炎是最常见的。本研究旨在探讨水提取物从八种药用植物(Helichrysum arenarium,Mentha Piperita,Candermain Ifficinalis,Taraxacum Officinale,Polygonum Aviculare,Matricaria Chamomilla,Portulaca Oleracea,Horticum Perforatum)的影响以及慢性胆囊炎患者的免疫反应性参数。结果发现,在45天期间的聚丙乙巴茶的消耗随后是肝脏生化指数的标准化(胆固醇血清水平,丙氨酸氨基转移酶和天冬氨酸氨基转移酶活性,总和未缀合的胆红素水平和血液天动病学的减少(白细胞增强的红细胞沉降率和中性粒细胞-To淋巴细胞比率和免疫学(血清血清血清血清水平)肝胆疾病患者的全身炎症的迹象。研究结果表明,研究的聚甲醛组合物可以作为补充疗法的组成部分慢性胆囊炎的患者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号